flecainide Tablets 50 mg, 100 mg

Dossier type
Dossier status
Ready to file
Country of origin
North Macedonia
GMP approvals
Registered in
MAs for sale
Type of application: Generic
Manufacturer #2692
A pharmaceutical manufacturer based in the EU that has been active in EU, CIS, and North America with 10+ branches for 80+ years. Key production lines are Rx and OTC drugs, medical devices, food supplements, chemical products, cosmetics, and herbal meds with EU GMP standards. The main dosage forms are solid and liquid oral and topical preparations. The company possesses its own R&D institute.

Manufacturer usually replies in 9 days

Markets of interest Flecainide is prescribed for preventing certain types of life threatening irregular heartbeats. As an antiarrhythmic drug, flecainide works by slowing electrical signals in the heart to stabilize the heart rhythm. The medication is prescribed to treat ventricular and subventricular tachycardias, abnormal heart rate over 100 beats per minute. Due to proarrhythmic properties of this medication and and lack of evidence of improved survival for any antiarrhythmics, the drug use should be restricted to patients with life-threatening ventricular arrhythmias. The drug is available for sale in different forms such as tablets (at concentrations of 50mg, 100mg, 150mg) and prolonged release (at concentrations of 50mg. 100mg. 150mg. 200mg) from manufacturers in various countries including Y. The leading flecainide manufacturers and distributors are based in India, Argentina and the United Kingdom. Licensing and brand names Flecainide was approved by the FDA for medical use in the United States in 1985 and available for sale as a generic medication. Flecainide is marketed under the brand name Tambocor and also sold in certain countries under such trade names as Flecaine, Apocard, Almarytm, and Ecrinal. The leading flecainide supplier and manufacturer is the Indian company Aurobindo. Other manufacturing companies from Macedonia, United States and European Union have also successfully adapted to the demands of the global marketplace and produce a variant of the drug with flecainide as an active ingredient. Target supply price The wholesale acquisition cost for flecainide oral tablets 50 mg is around 31 USD for a supply of 50, in the United States, and around 33 USD for the same amount of tablets at 100mg concentration. The retail price of this medication in the EU depending on this substance concentration in tablets ranges from 15 to 36 EUR for the same amount of tablets. The medication wholesale prices and commercial terms can vary depending on the supplier. Information from manufacturers We provide a detailed list of the flecainide manufacturers and suppliers that you are looking for. You can also find the dossier status of the drug that you order, and the GMP approvals of the different variants of the medication. The product description of all flecainide suppliers contains essential information about the medication, including clinical data, stability zones, and a list of countries where flecainide is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms as well as delivery terms.Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified flecainide suppliers and distributors enter our online marketplace, offering you a risk-free global B2B pharmaceutical sales platform.